Sub-chronic exposure to morphine alters general anesthetic potency by differentially regulating the expression of neurotransmitter receptor subunits in mice

Yali Chen,Mengchan Ou,Xuechao Hao,Peng Liang,Yan Liang,Yangyang Wang,Yu Li,Cheng Zhou
DOI: https://doi.org/10.1016/j.brainresbull.2021.01.009
IF: 3.715
2021-04-01
Brain Research Bulletin
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Sub-chronic exposure to morphine can increase the efficacy of propofol but decrease the efficacy of ketamine by unknown mechanisms. The present study was designed to investigate the effects of sub-chronic exposure to morphine on the expression of neurotransmitter receptor subunits, which might contribute to the efficacy changes of ketamine and propofol <em>in vivo</em>.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Sub-chronic exposure to morphine was established by administering subcutaneous injections of morphine for 5 consecutive days. The median effective dose (ED<sub>50</sub>) of ketamine and/or propofol was measured on day 1, day 3, day 7 and day 15, after the last morphine dosage. Mice in the sham group received an equal volume of normal saline. The expressions of N-methyl D-aspartate (NMDA) receptor and γ-aminobutyric acid A (GABA<sub>A</sub>) receptor subunits in the forebrain were measured. Knockdown or overexpression of a subunit was used to determine the causality between the change in anesthetic potency and the expression of an identified receptor subunit.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>After sub-chronic exposure of mice to morphine, the expression of NMDA receptor 1 (NR1) was most elevated in the forebrain on day 1 (<em>P</em> &lt; 0.0001 <em>vs.</em> sham). In contrast, the expression of GABA<sub>A</sub> receptor β3 (GABA<sub>A</sub>Rβ3) gradually decreased to its lowest level on day 7 (<em>P</em> = 0.005 <em>vs.</em> sham) in the forebrain. Regression analysis revealed that the expression of NR1 in the forebrain was relevant to the increased ED<sub>50</sub> of ketamine (<em>P</em> = 0.0002), while the expression of GABA<sub>A</sub>Rβ3 in the forebrain was relevant to the decreased ED<sub>50</sub> of propofol (<em>P</em> = 0.0051) after morphine exposure. Knockdown expression of NR1 in the forebrain reversed the elevated ED<sub>50</sub> of ketamine after morphine treatment. Overexpression of GABA<sub>A</sub>Rβ3 in the forebrain increased the ED<sub>50</sub> of propofol to the sham-level after morphine treatment.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Sub-chronic exposure to morphine can differentially modulate the expressions of NR1 and GABA<sub>A</sub>Rβ3 in mice, which may contribute to the changes in ED<sub>50</sub> of ketamine and propofol <em>in vivo</em>.</p>
neurosciences
What problem does this paper attempt to address?